First-of-its kind cartridge-based diagnostic tool, OptiCell, is now available for pre-sale in the UK with installations expected to start in January 2025.
Otomicol is licensed for use in cats and dogs, and is “specifically formulated for the treatment of otitis externa, as well as primary and secondary infections of the skin and adnexa”.
Online retailers and Trading Standards officials have been alerted to what the company described as “illegally copied” versions of its YuMOVE products.
Zoetis says Protivity is a “game-changer” research and development achievement decades in the making designed to stimulate required cell-mediated immune response in beef and dairy calves.
Furosoral is described as “a versatile new product for the initial treatment, or maintenance therapy, of conditions associated with fluid build-up in cats and dogs”.
Syvazul BTV3 is licensed to reduce viraemia, prevent mortality and reduce clinical signs and lesions in sheep and for the active immunisation against bluetongue virus serotype 3 in cattle.
Inactivated injectable vaccine indicated for the active immunisation against BTV-3 reduces viraemia, prevents mortality and reduces the clinical signs of in sheep and reduces viraemia in cattle.
Bovilis Cryptium from MSD is first vaccine proven to protect calves from the start of colostrum feeding against the highly infectious parasite behind the gastrointetinal disease.